BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
US Army
Dow
Harvard Business School
Farmers Insurance
AstraZeneca
Baxter
Federal Trade Commission
McKinsey
QuintilesIMS

Generated: January 20, 2018

DrugPatentWatch Database Preview

NOREPINEPHRINE BITARTRATE Drug Profile

« Back to Dashboard

Which patents cover Norepinephrine Bitartrate, and when can generic versions of Norepinephrine Bitartrate launch?

Norepinephrine Bitartrate is a drug marketed by Baxter Hlthcare Corp, Metrics Pharm, Teva Pharms Usa, and West-ward Pharms Int. and is included in four NDAs.

The generic ingredient in NOREPINEPHRINE BITARTRATE is norepinephrine bitartrate. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the norepinephrine bitartrate profile page.
Summary for NOREPINEPHRINE BITARTRATE
Drug patent expirations by year for NOREPINEPHRINE BITARTRATE
Pharmacology for NOREPINEPHRINE BITARTRATE
Ingredient-typeCatecholamines
Drug ClassCatecholamine
Medical Subject Heading (MeSH) Categories for NOREPINEPHRINE BITARTRATE

US Patents and Regulatory Information for NOREPINEPHRINE BITARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare Corp NOREPINEPHRINE BITARTRATE norepinephrine bitartrate INJECTABLE;INJECTION 040859-001 Mar 27, 2012 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int NOREPINEPHRINE BITARTRATE norepinephrine bitartrate INJECTABLE;INJECTION 040462-001 Oct 31, 2003 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Metrics Pharm NOREPINEPHRINE BITARTRATE norepinephrine bitartrate INJECTABLE;INJECTION 040522-001 Sep 30, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms Usa NOREPINEPHRINE BITARTRATE norepinephrine bitartrate INJECTABLE;INJECTION 040455-001 Mar 3, 2003 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Dow
Medtronic
Teva
Harvard Business School
Queensland Health
Citi
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot